Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) - Total Liabilities

Latest as of March 2026: CN¥640.98 Million CNY ≈ $93.79 Million USD

Based on the latest financial reports, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has total liabilities worth CN¥640.98 Million CNY (≈ $93.79 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Shanghai Shenqi Pharmaceutical Investmen (600613) long-term investment share to see how much of total assets are deployed in long-term investments.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A - Total Liabilities Trend (1992–2025)

This chart illustrates how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Shanghai Shenqi Pharmaceutical Investmen.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Competitors by Total Liabilities

The table below lists competitors of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A ranked by their total liabilities.

Company	Country	Total Liabilities
Autohellas S.A. AT:OTOEL	Greece	€1.20 Billion
Guangdong Banbao Toy Co Ltd SHG:603398	China	CN¥2.73 Billion
Greene County Bancorp Inc NASDAQ:GCBC	USA	$2.91 Billion
SmartFinancial, Inc. NASDAQ:SMBK	USA	$5.25 Billion
Fujian Raynen Tech Co Ltd SHG:603933	China	CN¥1.63 Billion
Zhejiang Tieliu Clutch Co Ltd SHG:603926	China	CN¥1.34 Billion
Shanghai New World Co Ltd SHG:600628	China	CN¥1.47 Billion
Chularat Hospital Public Company Limited BK:CHG-R	Thailand	฿2.21 Billion

Liability Composition Analysis (1992–2025)

This chart breaks down Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 600613 net asset quality score to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.61	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.28	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.21	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1992–2025)

The table below shows the annual total liabilities of Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A from 1992 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥747.59 Million ≈ $109.40 Million	+8.50%
2024-12-31	CN¥689.01 Million ≈ $100.82 Million	-22.48%
2023-12-31	CN¥888.77 Million ≈ $130.05 Million	-11.82%
2022-12-31	CN¥1.01 Billion ≈ $147.49 Million	+33.24%
2021-12-31	CN¥756.45 Million ≈ $110.69 Million	-1.79%
2020-12-31	CN¥770.28 Million ≈ $112.72 Million	-13.90%
2019-12-31	CN¥894.60 Million ≈ $130.91 Million	+69.51%
2018-12-31	CN¥527.74 Million ≈ $77.23 Million	-6.65%
2017-12-31	CN¥565.34 Million ≈ $82.73 Million	-0.39%
2016-12-31	CN¥567.56 Million ≈ $83.05 Million	+47.43%
2015-12-31	CN¥384.98 Million ≈ $56.33 Million	+50.62%
2014-12-31	CN¥255.60 Million ≈ $37.40 Million	+39.35%
2013-12-31	CN¥183.42 Million ≈ $26.84 Million	+654.66%
2012-12-31	CN¥24.31 Million ≈ $3.56 Million	-23.02%
2011-12-31	CN¥31.57 Million ≈ $4.62 Million	+10.85%
2010-12-31	CN¥28.48 Million ≈ $4.17 Million	-53.01%
2009-12-31	CN¥60.61 Million ≈ $8.87 Million	+14.26%
2008-12-31	CN¥53.04 Million ≈ $7.76 Million	-41.21%
2007-12-31	CN¥90.23 Million ≈ $13.20 Million	-14.22%
2006-12-31	CN¥105.19 Million ≈ $15.39 Million	-4.09%
2005-12-31	CN¥109.67 Million ≈ $16.05 Million	-40.71%
2004-12-31	CN¥184.98 Million ≈ $27.07 Million	+32.17%
2003-12-31	CN¥139.96 Million ≈ $20.48 Million	-2.39%
2002-12-31	CN¥143.38 Million ≈ $20.98 Million	-8.76%
2001-12-31	CN¥157.14 Million ≈ $22.99 Million	-7.00%
2000-12-31	CN¥168.97 Million ≈ $24.73 Million	+13.06%
1999-12-31	CN¥149.46 Million ≈ $21.87 Million	-61.11%
1998-12-31	CN¥384.28 Million ≈ $56.23 Million	+80.69%
1997-12-31	CN¥212.67 Million ≈ $31.12 Million	+26.19%
1996-12-31	CN¥168.53 Million ≈ $24.66 Million	-0.56%
1995-12-31	CN¥169.48 Million ≈ $24.80 Million	+7.14%
1994-12-31	CN¥158.19 Million ≈ $23.15 Million	+51.64%
1993-12-31	CN¥104.32 Million ≈ $15.27 Million	+23.97%
1992-12-31	CN¥84.15 Million ≈ $12.31 Million	--

About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A

SHG:600613 China Drug Manufacturers - General

Market Cap

$589.87 Million

CN¥4.03 Billion CNY

Market Cap Rank

#11501 Global

#3254 in China

Share Price

CN¥8.41

Change (1 day)

-1.52%

52-Week Range

CN¥4.44 - CN¥12.40

All Time High

CN¥24.35